Approach to Altered Mental Status in Pregnancy and Postpartum

Abstract

The evaluation and diagnosis of altered mental status in the pregnant or postpartum patient largely parallels the approach used for any other patient; however, there are several critical differences including that some neuroobstetric diagnoses require emergent delivery of the fetus. Being familiar with the physiological changes and medical complications of pregnancy and delivery is therefore essential. This review first addresses pregnancy-specific disorders that may result in altered mental status, such as the hypertensive disorders of pregnancy and pregnancy-related metabolic and endocrinopathies. The focus then shifts to the complex physiologic changes in pregnancy and how these changes contribute to the distinct epidemiology of pregnancy-related cerebrovascular complications like intracranial hemorrhage, ischemic stroke, and reversible cerebral vasoconstriction syndrome. Medical disorders that are not unique to pregnancy, such as infections and autoimmune conditions, may present de novo or worsen during pregnancy and the peripartum period and require a thoughtful approach to diagnosis and management. Finally, the unique nervous system complications of obstetric anesthesia are explored. In each section, there is a focus not only on diagnosis and syndrome recognition but also on the emergent treatment needed to reverse these complications, bearing in mind the unique physiology of the pregnant patient.

Keywords

pregnancy - altered mental status - encephalopathy - preeclampsia - stroke in pregnancy - eclampsia

Publication History

Article published online:
16 August 2024

• References

• 1 Gestational Hypertension and Preeclampsia. Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol 2020; 135 (06) e237-e260
• 2 Pregnancy Mortality Surveillance System 2017–2019. Centers for Disease Control and Prevention. Accessed January 30, 2024 at: https://www.cdc.gov/reproductivehealth/maternal-mortality/pregnancy-mortality-surveillance-system.htm#:∼:text=32.0%20deaths%20per%20100%2C000%20live,live%20births%20among%20Hispanic%20persons
• 3 Ford ND, Cox S, Ko JY. et al. Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019. MMWR Morb Mortal Wkly Rep 2022; 71 (17) 585-591
• 4 Say L, Chou D, Gemmill A. et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2014; 2 (06) e323-e333
• 5 Leffert LR, Clancy CR, Bateman BT, Bryant AS, Kuklina EV. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet Gynecol 2015; 125 (01) 124-131
• 6 Magee LA, Brown MA, Hall DR. et al. The 2021 International Society for the Study of Hypertension in Pregnancy classification, diagnosis & management recommendations for international practice. Pregnancy Hypertens 2022; 27: 148-169
• 7 Goel A, Maski MR, Bajracharya S. et al. Epidemiology and mechanisms of de novo and persistent hypertension in the postpartum period. Circulation 2015; 132 (18) 1726-1733
• 8 Al-Safi Z, Imudia AN, Filetti LC, Hobson DT, Bahado-Singh RO, Awonuga AO. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol 2011; 118 (05) 1102-1107
• 9 Churchill D, Duley L, Thornton JG, Moussa M, Ali HS, Walker KF. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation. Cochrane Database Syst Rev 2018; 10 (10) CD003106
• 10 Martin Jr JN, Rinehart BK, May WL, Magann EF, Terrone DA, Blake PG. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 1999; 180 (6, Pt 1): 1373-1384
• 11 Catanzarite VA, Steinberg SM, Mosley CA, Landers CF, Cousins LM, Schneider JM. Severe preeclampsia with fulminant and extreme elevation of aspartate aminotransferase and lactate dehydrogenase levels: high risk for maternal death. Am J Perinatol 1995; 12 (05) 310-313
• 12 Knight M. UKOSS. Eclampsia in the United Kingdom 2005. BJOG 2007; 114 (09) 1072-1078
• 13 Berhan Y, Berhan A. Should magnesium sulfate be administered to women with mild pre-eclampsia? A systematic review of published reports on eclampsia. J Obstet Gynaecol Res 2015; 41 (06) 831-842
• 14 Cooray SD, Edmonds SM, Tong S, Samarasekera SP, Whitehead CL. Characterization of symptoms immediately preceding eclampsia. Obstet Gynecol 2011; 118 (05) 995-999
• 15 Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309 (6966): 1395-1400
• 16 Anderson RC, Patel V, Sheikh-Bahaei N. et al. Posterior reversible encephalopathy syndrome (PRES): pathophysiology and neuro-imaging. Front Neurol 2020; 11: 463
• 17 Hinchey J, Chaves C, Appignani B. et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (08) 494-500
• 18 Verma AK, Garg RK, Pradeep Y. et al. Posterior encephalopathy syndrome in women with eclampsia: predictors and outcome. Pregnancy Hypertens 2017; 10: 74-82
• 19 Mayama M, Uno K, Tano S. et al. Incidence of posterior reversible encephalopathy syndrome in eclamptic and patients with preeclampsia with neurologic symptoms. Am J Obstet Gynecol 2016; 215 (02) 239.e1-239.e5
• 20 Fisher N, Saraf S, Egbert N, Homel P, Stein EG, Minkoff H. Clinical correlates of posterior reversible encephalopathy syndrome in pregnancy. J Clin Hypertens (Greenwich) 2016; 18 (06) 522-527
• 21 Brewer J, Owens MY, Wallace K. et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am J Obstet Gynecol 2013; 208 (06) 468.e1-468.e6
• 22 Bahadur A, Mundhra R, Singh R. et al. Predictors of posterior reversible encephalopathy syndrome (PRES) in women with pre-eclampsia/eclampsia: a retrospective analysis. Cureus 2022; 14 (11) e31459
• 23 Ibdah JA, Bennett MJ, Rinaldo P. et al. A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 1999; 340 (22) 1723-1731
• 24 Castro MA, Fassett MJ, Reynolds TB, Shaw KJ, Goodwin TM. Reversible peripartum liver failure: a new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 1999; 181 (02) 389-395
• 25 Nelson DB, Yost NP, Cunningham FG. Acute fatty liver of pregnancy: clinical outcomes and expected duration of recovery. Am J Obstet Gynecol 2013; 209 (05) 456.e1-456.e7
• 26 Reyes LM, Usselman CW, Davenport MH, Steinback CD. Sympathetic nervous system regulation in human normotensive and hypertensive pregnancies. Hypertension 2018; 71 (05) 793-803
• 27 Knight M, Nelson-Piercy C, Kurinczuk JJ, Spark P, Brocklehurst P. UK Obstetric Surveillance System. A prospective national study of acute fatty liver of pregnancy in the UK. Gut 2008; 57 (07) 951-956
• 28 Wu Z, Huang P, Gong Y, Wan J, Zou W. Treating acute fatty liver of pregnancy with artificial liver support therapy: systematic review. Medicine (Baltimore) 2018; 97 (38) e12473
• 29 Ch'ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002; 51 (06) 876-880
• 30 Lockwood CJ, Moore T, Copel J, Silver RM. Creasy and Resnik's Maternal-Fetal Medicine. Elsevier; 2022
• 31 Stanley M, Killeen RB, Michalski JM. Thrombotic Thrombocytopenic Purpura. StatPearls: StatPearls Publishing; 2024
• 32 Rock GA, Shumak KH, Buskard NA. et al; Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 1991; 325 (06) 393-397
• 33 Thompson CE, Damon LE, Ries CA, Linker CA. Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic. Blood 1992; 80 (08) 1890-1895
• 34 Delmas Y, Helou S, Chabanier P. et al. Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease. BMC Pregnancy Childbirth 2015; 15 (01) 137
• 35 Scully M, Thomas M, Underwood M. et al; Collaborators of the UK TTP Registry. Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes. Blood 2014; 124 (02) 211-219
• 36 Page EE, Kremer Hovinga JA, Terrell DR, Vesely SK, George JN. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 2017; 1 (10) 590-600
• 37 Weil EL, Rabinstein AA. Neurological manifestations of thrombotic microangiopathy syndromes in adult patients. J Thromb Thrombolysis 2021; 51 (04) 1163-1169
• 38 Cines DB, Levine LD. Thrombocytopenia in pregnancy. Hematology (Am Soc Hematol Educ Program) 2017; 2017 (01) 144-151
• 39 Wind M, Gaasbeek AGA, Oosten LEM. et al. Therapeutic plasma exchange in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol 2021; 260: 29-36
• 40 Fakhouri F, Roumenina L, Provot F. et al. Pregnancy-associated hemolytic uremic syndrome revisited in the era of complement gene mutations. J Am Soc Nephrol 2010; 21 (05) 859-867
• 41 Gupta M, Govindappagari S, Burwick RM. Pregnancy-associated atypical hemolytic uremic syndrome: a systematic review. Obstet Gynecol 2020; 135 (01) 46-58
• 42 Oudman E, Wijnia JW, Oey MJ, van Dam M, Postma A. Wernicke-Korsakoff syndrome despite no alcohol abuse: a summary of systematic reports. J Neurol Sci 2021; 426: 117482
• 43 Oudman E, Wijnia JW, Oey M, van Dam M, Painter RC, Postma A. Wernicke's encephalopathy in hyperemesis gravidarum: a systematic review. Eur J Obstet Gynecol Reprod Biol 2019; 236: 84-93
• 44 Lassey SC, Napoe GS, Carusi D, Schantz-Dunn J, Robinson JN. Hyponatremia among parturients transferred to the hospital after prolonged labor during an attempted home birth. Obstet Gynecol 2019; 134 (01) 106-108
• 45 da Silva JSV, Seres DS, Sabino K. et al; Parenteral Nutrition Safety and Clinical Practice Committees, American Society for Parenteral and Enteral Nutrition. ASPEN consensus recommendations for refeeding syndrome. Nutr Clin Pract 2020; 35 (02) 178-195
• 46 Gregory EC, Ely DM. Trends and characteristics in gestational diabetes: United States, 2016-2020. Natl Vital Stat Rep 2022; 71 (03) 1-15
• 47 Centers for Disease Control and Prevention. National Diabetes Statistics Report. Accessed February 24, 2024 at: https://www.cdc.gov/diabetes/data/statistics-report/index.html
• 48 García-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 2010; 53 (03) 446-451
• 49 ElSayed NA, Aleppo G, Aroda VR. et al; On Behalf of the American Diabetes Association. 15. Management of diabetes in pregnancy: standards of care in diabetes-2023. Diabetes Care 2023; 46 (Suppl. 01) S254-S266
• 50 Pitteloud N, Binz K, Caulfield A, Philippe J. Ketoacidosis during gestational diabetes. Case report. Diabetes Care 1998; 21 (06) 1031-1032
• 51 Dhanasekaran M, Mohan S, Erickson D. et al. Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes. J Clin Endocrinol Metab 2022; 107 (11) 3137-3143
• 52 Guo R-X, Yang L-Z, Li L-X, Zhao X-P. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res 2008; 34 (03) 324-330
• 53 Mordes JP, Wacker WE. Excess magnesium. Pharmacol Rev 1977; 29 (04) 273-300
• 54 Walker P, Parnell S, Dillon RC. Epsom salt ingestion leading to severe hypermagnesemia necessitating dialysis. J Emerg Med 2020; 58 (05) 767-770
• 55 Yamaguchi H, Shimada H, Yoshita K. et al. Severe hypermagnesemia induced by magnesium oxide ingestion: a case series. CEN Case Rep 2019; 8 (01) 31-37
• 56 Picolos MK, Sims CR, Mastrobattista JM, Carroll MA, Lavis VR. Milk-Alkali syndrome in pregnancy. Obstet Gynecol 2004; 104 (5, Pt 2): 1201-1204
• 57 Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 1976; 21 (11) 953-956
• 58 Marrero JM, Goggin PM, de Caestecker JS, Pearce JM, Maxwell JD. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 1992; 99 (09) 731-734
• 59 Schertz AR, Sarma AK, Datar S, Miller PJ. Reversible cerebral vasoconstriction syndrome (RCVS) caused by over-the-counter calcium supplement ingestion. BMJ Case Rep 2021; 14 (01) e233877
• 60 Liu L, Su G, Wang S, Zhu B. The prevalence of obstructive sleep apnea and its association with pregnancy-related health outcomes: a systematic review and meta-analysis. Sleep Breath 2019; 23 (02) 399-412
• 61 Pien GW, Pack AI, Jackson N, Maislin G, Macones GA, Schwab RJ. Risk factors for sleep-disordered breathing in pregnancy. Thorax 2014; 69 (04) 371-377
• 62 Taylor PN, Albrecht D, Scholz A. et al. Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol 2018; 14 (05) 301-316
• 63 Rotondi M, Cappelli C, Pirali B. et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008; 93 (10) 3985-3988
• 64 Rajasekaran S, Vanderpump M, Baldeweg S. et al. UK guidelines for the management of pituitary apoplexy. Clin Endocrinol (Oxf) 2011; 74 (01) 9-20
• 65 Powers P, Jan K, Bommisetty D. Adrenal crisis in a delayed diagnosis of Sheehan syndrome. Cureus 2023; 15 (08) e44225
• 66 Parikh R, Buch V, Makwana M, Buch HN. The price of a 15-year delay in diagnosis of Sheehan's syndrome. Proc Bayl Univ Med Cent 2016; 29 (02) 212-213
• 67 Swartz RH, Cayley ML, Foley N. et al. The incidence of pregnancy-related stroke: a systematic review and meta-analysis. Int J Stroke 2017; 12 (07) 687-697
• 68 Liu S, Chan W-S, Ray JG, Kramer MS, Joseph KS. Stroke and cerebrovascular disease in pregnancy. Stroke 2019; 50 (01) 13-20
• 69 Cheng CA, Lee JT, Lin HC. et al. Pregnancy increases stroke risk up to 1 year postpartum and reduces long-term risk. QJM 2017; 110 (06) 355-360
• 70 Takahashi JC, Iihara K, Ishii A, Watanabe E, Ikeda T, Miyamoto S. Pregnancy-associated intracranial hemorrhage: results of a survey of neurosurgical institutes across Japan. J Stroke Cerebrovasc Dis 2014; 23 (02) e65-e71
• 71 Yoshida K, Takahashi JC, Takenobu Y, Suzuki N, Ogawa A, Miyamoto S. Strokes associated with pregnancy and puerperium: a nationwide study by the Japan Stroke Society. Stroke 2017; 48 (02) 276-282
• 72 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31 (06) 1274-1282
• 73 Song TJ, Lee KH, Li H. et al. Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci 2021; 25 (09) 3519-3529
• 74 Mitchell LA, Santarelli JG, Singh IP, Do HM. Reversible cerebral vasoconstriction syndrome and bilateral vertebral artery dissection presenting in a patient after cesarean section. J Neurointerv Surg 2014; 6 (01) e5
• 75 Salehi Omran S, Parikh NS, Poisson S. et al. Association between pregnancy and cervical artery dissection. Ann Neurol 2020; 88 (03) 596-602
• 76 Bulsara VM, Bulsara MK, Codde J, Preen D, Slack-Smith L, O'Donnell M. Injuries in mothers hospitalised for domestic violence-related assault: a whole-population linked data study. BMJ Open 2021; 11 (05) e040600
• 77 Virani SS, Alonso A, Aparicio HJ. et al; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: a report from the American Heart Association. Circulation 2021; 143 (08) e254-e743
• 78 Lappin JM, Darke S, Duflou J, Kaye S, Farrell M. Fatal stroke in pregnancy and the puerperium. Stroke 2018; 49 (12) 3050-3053
• 79 Koczo A, Marino A, Rocco J. et al; IPAC Investigators. Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy. Int J Cardiol 2021; 339: 93-98
• 80 Li Y, Margraf J, Kluck B, Jenny D, Castaldo J. Thrombolytic therapy for ischemic stroke secondary to paradoxical embolism in pregnancy: a case report and literature review. Neurologist 2012; 18 (01) 44-48
• 81 Powers WJ, Rabinstein AA, Ackerson T. et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50 (12) e344-e418
• 82 Ladhani NNN, Swartz RH, Foley N. et al. Canadian Stroke Best Practice Consensus Statement: acute stroke management during pregnancy. Int J Stroke 2018; 13 (07) 743-758
• 83 Committee Opinion No. Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation. Obstet Gynecol 2017; 130 (04) e210-e216
• 84 Miller EC. Maternal stroke associated with pregnancy. Continuum (Minneap Minn) 2022; 28 (01) 93-121
• 85 Puac P, Rodríguez A, Vallejo C, Zamora CA, Castillo M. Safety of contrast material use during pregnancy and lactation. Magn Reson Imaging Clin N Am 2017; 25 (04) 787-797
• 86 Dicpinigaitis AJ, Sursal T, Morse CA. et al. Endovascular thrombectomy for treatment of acute ischemic stroke during pregnancy and the early postpartum period. Stroke 2021; 52 (12) 3796-3804
• 87 Al-Mufti F, Schirmer CM, Starke RM. et al; SNIS Standards and Guidelines Committee and SNIS Board of Directors. Thrombectomy in special populations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. J Neurointerv Surg 2022; 14 (10) 1033-1041
• 88 Miller EC, Gatollari HJ, Too G. et al. Risk factors for pregnancy-associated stroke in women with preeclampsia. Stroke 2017; 48 (07) 1752-1759
• 89 Johnson CY, Rocheleau CM, Howley MM, Chiu SK, Arnold KE, Ailes EC. Characteristics of women with urinary tract infection in pregnancy. J Womens Health (Larchmt) 2021; 30 (11) 1556-1564
• 90 Resnik R, Lockwood CJ, Creasy RK. et al. Creasy and Resnik's Maternal-Fetal Medicine: Principles and Practice E-Book. Elsevier - Health Sciences Division; 2008
• 91 Wing DA, Fassett MJ, Getahun D. Acute pyelonephritis in pregnancy: an 18-year retrospective analysis. Am J Obstet Gynecol 2014; 210 (03) 219.e1-219.e6
• 92 Grette K, Cassity S, Holliday N, Rimawi BH. Acute pyelonephritis during pregnancy: a systematic review of the aetiology, timing, and reported adverse perinatal risks during pregnancy. J Obstet Gynaecol 2020; 40 (06) 739-748
• 93 Miller EC, Gallo M, Kulick ER, Friedman AM, Elkind MSV, Boehme AK. Infections and risk of peripartum stroke during delivery admissions. Stroke 2018; 49 (05) 1129-1134
• 94 Bundhun PK, Soogund MZ, Huang F. Impact of systemic lupus erythematosus on maternal and fetal outcomes following pregnancy: a meta-analysis of studies published between years 2001-2016. J Autoimmun 2017; 79: 17-27
• 95 Dao KH, Bermas BL. Systemic lupus erythematosus management in pregnancy. Int J Womens Health 2022; 14: 199-211
• 96 Nguyen NV, Svenungsson E, Dominicus A. et al. Hydroxychloroquine in lupus or rheumatoid arthritis pregnancy and risk of major congenital malformations: a population-based cohort study. Rheumatology (Oxford) 2024; keae168
• 97 Cervera R, Rodríguez-Pintó I, Colafrancesco S. et al. 14th International Congress on Antiphospholipid Antibodies Task Force Report on catastrophic antiphospholipid syndrome. Autoimmun Rev 2014; 13 (07) 699-707
• 98 Gómez-Puerta JA, Cervera R, Espinosa G. et al. Catastrophic antiphospholipid syndrome during pregnancy and puerperium: maternal and fetal characteristics of 15 cases. Ann Rheum Dis 2007; 66 (06) 740-746
• 99 Han A, Lee SK, Park JC, Park CW, Han JW, Lee KH. Maternal and fetal safety of intravenous immunoglobulin in women with reproductive failure. Am J Reprod Immunol 2021; 86 (06) e13492
• 100 D'Mello RJ, Hsu CD, Chaiworapongsa P, Chaiworapongsa T. Update on the use of intravenous immunoglobulin in pregnancy. Neoreviews 2021; 22 (01) e7-e24
• 101 Waters JFR. Neurologic complications of obstetric anesthesia. Continuum (Minneap Minn) 2022; 28 (01) 162-179
• 102 Schweiger V, Zanconato G, Lonati G, Baggio S, Gottin L, Polati E. Intracranial subdural hematoma after spinal anesthesia for cesarean section. Case Rep Obstet Gynecol 2013; 2013: 253408
• 103 Amorim JA, Remígio DS, Damázio Filho O, de Barros MA, Carvalho VN, Valença MM. Intracranial subdural hematoma post-spinal anesthesia: report of two cases and review of 33 cases in the literature. Rev Bras Anestesiol 2010; 60 (06) 620-629 , 344–349
• 104 Reynolds F. Neurological infections after neuraxial anesthesia. Anesthesiol Clin 2008; 26 (01) 23-52 , v
• 105 Dickerson DM, Apfelbaum JL. Local anesthetic systemic toxicity. Aesthet Surg J 2014; 34 (07) 1111-1119
• 106 Grape S, Kirkham KR, Albrecht E. Transversus abdominis plane block versus local anaesthetic wound infiltration for analgesia after caesarean section: a systematic review and meta-analysis with trial sequential analysis. Eur J Anaesthesiol 2022; 39 (03) 244-251
• 107 Di Gregorio G, Neal JM, Rosenquist RW, Weinberg GL. Clinical presentation of local anesthetic systemic toxicity: a review of published cases, 1979 to 2009. Reg Anesth Pain Med 2010; 35 (02) 181-187
• 108 Ciechanowicz S, Patil V. Lipid emulsion for local anesthetic systemic toxicity. Anesthesiol Res Pract 2012; 131784
• 109 Miller EC, Vollbracht S. Neurology of Preeclampsia and Related Disorders: An update in Neuro-obstetrics. Curr Pain Headache Rep 2021; 25 (06) 40